Takeda Pharmaceutical Co Ltd ADR Dividends

The next dividend date for Takeda Pharmaceutical Co Ltd ADR has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Takeda Pharmaceutical Co Ltd ADR (TAK)

Date	Declaration Date	Record Date	Payment Date	Amount
03/31/2025	03/04/2025	03/31/2025	07/07/2025	$0.34
09/30/2024	09/12/2024	09/30/2024	12/12/2024	$0.33
03/27/2024	03/14/2024	03/28/2024	07/08/2024	$0.30
09/28/2023	09/13/2023	09/29/2023	12/11/2023	$0.32
03/30/2023	03/15/2023	03/31/2023	07/10/2023	$0.31
09/29/2022	09/13/2022	09/30/2022	12/12/2022	$0.30
03/30/2022	03/04/2022	03/31/2022	07/11/2022	$0.28
09/29/2021	---	09/30/2021	12/13/2021	$0.35
03/30/2021	03/15/2021	03/31/2021	07/12/2021	$0.40
09/29/2020	---	09/30/2020	12/11/2020	$0.38
03/30/2020	---	03/31/2020	07/06/2020	$0.32
09/27/2019	---	09/30/2019	12/12/2019	$0.32
03/28/2019	03/15/2019	03/29/2019	07/10/2019	$0.30
03/27/2019	---	03/31/2019	06/28/2019	$0.36
09/27/2018	09/07/2018	09/28/2018	12/13/2018	$0.40
09/26/2018	09/07/2018	09/28/2018	12/13/2018	$0.30
03/28/2018	03/14/2018	03/29/2018	07/09/2018	$0.41
03/27/2018	03/14/2018	03/29/2018	07/09/2018	$0.30
09/28/2017	09/19/2017	09/29/2017	12/11/2017	$0.40
09/27/2017	09/19/2017	09/29/2017	12/11/2017	$0.31
03/30/2017	03/15/2017	03/31/2017	07/10/2017	$0.40
03/29/2017	03/15/2017	03/31/2017	07/10/2017	$0.36
09/29/2016	09/15/2016	09/30/2016	12/12/2016	$0.39
09/28/2016	---	---	---	$0.29
03/30/2016	03/15/2016	03/31/2016	07/11/2016	$0.44
03/29/2016	---	---	---	$0.32
09/29/2015	12/01/2015	09/30/2015	12/11/2015	$0.37
09/28/2015	---	---	---	$0.28
03/30/2015	06/30/2015	03/31/2015	07/09/2015	$0.37
03/27/2015	---	---	---	$0.33
09/28/2014	12/03/2014	09/29/2014	12/11/2014	$0.38
09/26/2014	09/11/2014	---	12/11/2014	$0.29
03/27/2014	07/01/2014	03/28/2014	07/10/2014	$0.37
09/26/2013	12/04/2013	09/27/2013	12/12/2013	$0.43
03/27/2013	06/27/2013	03/28/2013	07/08/2013	$0.45
09/26/2012	12/04/2012	09/27/2012	12/13/2012	$0.55
03/28/2012	---	03/29/2012	07/09/2012	$0.50
09/28/2011	---	09/29/2011	12/12/2011	$0.51
03/29/2011	---	03/30/2011	07/07/2011	$0.49
09/28/2010	---	09/29/2010	12/13/2010	$0.53
09/27/2010	---	---	---	$0.50
03/29/2010	---	---	---	$0.45
09/25/2009	---	09/29/2009	12/15/2009	$0.46
03/26/2009	---	03/30/2009	07/14/2009	$0.42
09/25/2008	---	09/29/2008	12/16/2008	$0.41
03/26/2008	---	---	---	$0.36

More About Takeda Pharmaceutical Co Ltd ADR

Website

https://www.takeda.com

Country

USA

Full Time Employees

47,455

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.

Owning Takeda Pharmaceutical Co Ltd ADR Stock on the Dividend Date

If you own Takeda Pharmaceutical Co Ltd ADR stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Takeda Pharmaceutical Co Ltd ADR stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Takeda Pharmaceutical Co Ltd ADR stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Takeda Pharmaceutical Co Ltd ADR stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Takeda Pharmaceutical Co Ltd ADR dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Takeda Pharmaceutical Co Ltd ADR Dividends

You can contact us any time if you would like to ask questions about Takeda Pharmaceutical Co Ltd ADR dividends or anything else related to the stock market.